Showing 1,321 - 1,340 results of 2,530 for search '"vaccines"', query time: 0.05s Refine Results
  1. 1321
  2. 1322
  3. 1323
  4. 1324

    Thanks to Reviewers

    Published 2025-01-01
    “…Therapeutic Advances in Vaccines and Immunotherapy…”
    Get full text
    Article
  5. 1325
  6. 1326
  7. 1327

    A single residue switch mediates the broad neutralization of Rotaviruses by Yang Huang, Feibo Song, Yuanjun Zeng, Hui Sun, Roufang Sheng, Xuechun Wang, Liqin Liu, Guoxing Luo, Yanan Jiang, Yaling Chen, Mengxuan Zhang, Shiyin Zhang, Ying Gu, Hai Yu, Shaowei Li, Tingdong Li, Qingbing Zheng, Shengxiang Ge, Jun Zhang, Ningshao Xia

    Published 2025-01-01
    “…These findings define an atypical NAbs’ neutralization mechanism and reveal a potential type of virus vulnerable site for universal vaccine and therapeutics design.…”
    Get full text
    Article
  8. 1328
  9. 1329
  10. 1330
  11. 1331

    COVID-19: Understanding the New Variants of Concern by Ke-Yan Loo, Vengadesh Letchumanan

    Published 2022-12-01
    “…The first variant was Alpha, followed by the discovery of Beta, Gamma, Delta, and Omicron, being the latest variant of concern. Although vaccines were distributed worldwide to reduce the severity of the disease when infected with SARS-CoV-2, the emergence of new variants raised doubts about the efficacy of the available vaccines. …”
    Get full text
    Article
  12. 1332
  13. 1333

    Leveraging mRNA technology for antigen based immuno-oncology therapies by Wei Zheng, Michele Ceccarelli, Charalampos S Floudas, Siranush Sarkizova

    Published 2025-01-01
    “…While this review centers on therapeutic mRNA vaccines targeting existing tumors, it does not cover preventative vaccines. …”
    Get full text
    Article
  14. 1334
  15. 1335
  16. 1336
  17. 1337

    Antigen Gene Transfer to Human Plasmacytoid Dendritic Cells Using Recombinant Adenovirus and Vaccinia Virus Vectors by Hetty J. Bontkes, Janneke J. Ruizendaal, Marco W. J. Schreurs, Duco Kramer, Chris J. L. M. Meijer, Erik Hooijberg

    Published 2005-01-01
    “…Recombinant adenoviruses (RAd) and recombinant vaccinia viruses (RVV) expressing tumour-associated antigens (TAA) are used as anti-tumour vaccines. It is important that these vaccines deliver the TAA to dendritic cells (DC) for the induction of a strong immune response. …”
    Get full text
    Article
  18. 1338
  19. 1339
  20. 1340